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In mammalian cells, proteins involved in mRNA silencing and degradation localize to discrete
cytoplasmic foci called processing or P-bodies. Here we show that microscopically visible P-bodies
are greatly diminished following West Nile viral infection, but the component proteins are not
depleted. On the other hand, many P-body components including LSM1, GW182, DDX3, DDX6 and
XRN1, but not others like DCP1a and EDC4 are recruited to the viral replication sites, as evidenced by
their colocalization at perinuclear region with viral NS3. Kinetic studies suggest that the component
proteins are ﬁrst released from P-bodies in response to WNV infection within 12 h post-infection,
followed by recruitment to the viral replication sites by 24–36 h post-infection. Silencing of the
recruited proteins individually with siRNA interfered with viral replication to varying extents
suggesting that the recruited proteins are required for efﬁcient viral replication. Thus, the P-body
proteins might provide novel drug targets for inhibiting viral infection.
& 2012 Elsevier Inc. All rights reserved.Introduction
West Nile virus (WNV) is a mosquito borne ﬂavivirus that can
cause serious and potentially fatal infection of the central nervous
system, with up to 10% mortality in humans (Mackenzie et al.,
2004; Rappole et al., 2000). Currently there is neither a speciﬁc
treatment nor an approved vaccine for this infection. The viral
genome is a single stranded positive sense RNA of 11 kb that
encodes a single open reading frame ﬂanked by 50 and 30
untranslated regions (UTR). The genomic RNA encodes a single
polyprotein of approximately 3000 amino acid that is cleaved into
three structural and seven nonstructural proteins by cellular and
viral proteases. The three structural proteins are required for
virion assembly and the nonstructural (NS) proteins (NS1, NS2A,
NS2B, NS3, NS4A, NS4B and NS5) are all necessary for genome
replication (Lindenbach and Rice, 2003).
In mammalian cells, a subset of cellular proteins involved in
mRNA remodeling, decay and translational repression colocalize
in discrete cytoplasmic domains referred to as processing (P),
XRN1 or GW bodies (Eulalio et al., 2007; Eystathioy et al., 2002,
2003). The components of P-bodies include the decapping pro-
teins DCP1a–DCP2 complex, the CCR4–CAF1–NOT deadenylase
complex, and the 50–30 exonuclease XRN1 (Bagga et al., 2005;ll rights reserved.
. Manjunath).Behm-Ansmant et al., 2006; Giraldez et al., 2006; Wu et al., 2006).
In addition the P-bodies contain a set of decapping activators such
as the heteroheptomeric LSM1-7, proteins involved in the RNAi
pathway such as the Ago proteins and GW182, as well as the DEAD-
box helicases DDX3 and DDX6 (RCK/p54). P-bodies are thought to
be sites where untranslated mRNAs are stored for later release or
where mRNAs undergo decay and translational repression.
The genomic RNA of positive sense RNA viruses (like WNV)
serves essentially as mRNA that is used for translation of viral
proteins. However during viral replication, the RNA has to exit from
translation to serve as templates for packaging into new virions.
Thus not surprisingly, many RNA viruses interact with P-bodies in
some way (Beckham and Parker, 2008). For example in Yeast, Brome
mosaic virus genomic RNA and viral replication factors accumulate
in P-bodies. In mammalian viruses, DDX3 is required for cytoplasmic
transport of HIV genomic RNA (Garbelli et al., 2011; Yedavalli et al.,
2004). DDX3 also interacts with hepatitis C virus core protein and
DDX3 as well as DDX6 are required for HCV replication (Angus et al.,
2010; Ariumi et al., 2007; Jangra et al., 2010). A recent study has
reported that HCV hijacks many of the P-body and stress granule
components into lipid droplets involved in HCV replication (Ariumi
et al., 2011). Recently, we and others have reported that P-bodies are
greatly diminished during West Nile virus infection (Chen et al.,
2011; Emara and Brinton, 2007). However, what happens to P-body
proteins during WNV infection remains to be determined. Thus, in
this study, we examined the fate of P-body components during
WNV infection.
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Since microscopically visible P-bodies disappear after WNV
infection, we ﬁrst tested if the P-body proteins are depleted
following infection. Western blot analysis was done on cell
lysates of uninfected or WNV infected (MOI 2 and 36 h PI) HeLa
cells. Interestingly we found similar protein expression levels of
DDX3, DDX6, XRN1, LSM1, GW182 and DCP1a in uninfected and
WNV infected HeLa cells (Fig. 1). For GW182, we have recently
reported that its mRNA level indeed increases following WNV
infection (Chen et al., 2011). We also measured the mRNA
expression levels of DDX3, LSM1, Ago2 and Dicer in WNV infected
cells and found that the mRNA levels were indeed increased by
2–4 folds (data not shown). The reason why mRNA levels are
increased although protein levels remain the same is not clear.
Protein half-life may be decreased following infection or alter-
natively, certain cellular miRNAs may repress protein expression
following infection. More importantly, our results show that the
P-body disruption is not a result of depletion of P-body compo-
nents. This is in agreement with a recent study which showed
that in HCV infected cells, although P-bodies are disrupted, the
protein levels of P-body components were unaffected
(Pe´rezVilaro´ et al., 2012). This is also consistent with our previous
ﬁnding that both siRNA and miRNA pathways are intact following
infection (Chen et al., 2011).
Because P-body component proteins remained intact although
P-bodies were disrupted, we investigated the possible interaction
of WNV with the P-body proteins. Speciﬁcally, we examined the
localization of GW182, LSM1, DDX3, DDX6, XRN1, XRN2, DCP1a
and EDC4 proteins with respect to viral NS3 (which accumulates
at viral replication sites) in infected HeLa cells using immuno-
ﬂuorescence and confocal microscopy. The cells were infected
with WNV at MOI of 2 and 36 h post-infection the cells were
ﬁxed, permeabilized, blocked and stained for WNV using NS3
antibody. The cells were also stained with GW182, LSM1, DDX3,
DDX6, XRN1, XRN2, DCP1a or EDC4 antibodies and the nuclei
were stained with DAPI. We observed that in the uninfected HeLaFig. 1. WNV infection does not alter the protein levels of P-body components.
Uninfected (mock) and WNV infected (36 h post-infection) HeLa cell lysates were
analyzed for the expression of indicated proteins by Western blot using antibodies
to LSM1, DDX6, GW182, XRN1, DCP1a, DDX3, and WNV NS3. b-actin served as
loading control. The experiment was repeated twice with similar results.cells, the P-body proteins localized in discrete cytoplasmic
P-bodies and/or dispersed in the cell cytoplasm to varying extents.
In striking contrast, in infected cells, GW182, LSM1, DDX3, DDX6
and XRN1 were intensely concentrated in perinuclear regions and
colocalized with the viral NS 3 (Fig. 2a–e). However, the P-body
proteins, DCP1a and EDC4 or the non P-body XRN-2 did not
colocalize with NS-3, but were diffusely distributed in the
cytoplasm or nucleus (XRN 2) (Fig. 2f–h). These results suggest
that many, but not all components of P-bodies are recruited to
viral replication sites. Although DCP1a and EDC4 were not
recruited to viral replication sites, they were not visualized in
P-bodies after infection (but rather distributed in the cytoplasm).
This is probably because in the absence of essential components
like GW182, LSM1, DDX3 and XRN1, the P-bodies could no longer
be detected as discrete microscopic foci. Why DCP1a and EDC4
are not recruited to WNV replication sites, although other P-body
proteins are, is not clear. However similar to our results, Scheller
et al. (2009) found that DCP1a was not required for translation
and replication of HCV virus, whereas other P-body components
like LSm1-7 were needed. XRN2 is a nuclear protein and does
not concentrate in P-bodies and we used it as an unrelated
protein marker to show the speciﬁcity of redistribution of
P-body components.
We also conﬁrmed that viral replication intermediates are
concentrated in the perinuclear regions using an antibody against
double-stranded RNA (Fig. 2i). Moreover, upon staining the infected
cells with viral NS3 or dsRNA antibodies along with the endoplas-
mic reticulum (ER) marker, calnexin, we observed that both dsRNA
and NS3 colocalize with calnexin (Fig. 2j). This is consistent with
the fact that viral RNA replication occurs inside perinuclear replica-
tion complexes located inside vesicles that are invaginations of
rough ER membranes (Gillespie et al., 2010). The newly transcribed
genomic viral RNA exits the replication complex through the neck
of these vesicles and is either used for translation of viral proteins
or binds to capsid proteins associated with ER membranes leading
to virion budding into the lumen of the ER (Gillespie et al., 2010).
Further studies are necessary to determine the exact role of P-body
components in these processes.
Next, we studied the time course of disruption of P-bodies,
relocalization and the colocalization of LSM1, GW182, DDX3 and
XRN1 with WNV NS3 at the viral replication sites. We infected
HeLa cells with WNV at a MOI of 1. Cells were ﬁxed 12, 24 and
36 h post-infection, permeabilized, blocked and immunostained
for P-body components as described earlier. In uninfected cells,
GW182, LSM1, XRN1 and DDX3 were concentrated in punctate P-
bodies dispersed throughout the cell cytoplasm. In response to
WNV infection at 12 h PI, we observed a decrease in both the
number and brightness of P-bodies and an increase in the
presence of LSM1, GW182, DDX3 and XRN1 in the cell cytoplasm.
At 24 h PI all these proteins started accumulating around the
nucleus at the virus replication site, and their colocalization with
WNV NS3 was evident. At 36 h PI, the proteins were completely
recruited and very little cytoplasmic staining was visible (Fig. 3a–d).
These results suggest that early after infection, P-bodies are
disrupted and the component proteins released into the cyto-
plasm. Active recruitment at viral replication sites starts at 24 h
and is rapidly completed by 36 h PI.
P-body components can differentially affect virus replication. For
e.g. RCK/p54, GW182, LSM1 and XRN1 suppress HIV infection and
silencing these proteins enhances viral replication (Chable-Bessia
et al., 2009; Nathans et al., 2009). On the other hand, many P-body
components are needed for efﬁcient replication of Hepatitis C virus
(Ariumi et al., 2007, 2011). Therefore, we asked whether P-body
components are negative or positive regulators of WNV replication.
We transiently transfected HeLa cells with smart pool siRNA for
each of LSM1, DDX3, Ago2, Dicer and GW182 proteins and a non
Fig. 2. Several P-body components are recruited to WNV replication sites. Uninfected and WNV infected (36 h post-infection) HeLa cells were stained with DAPI, WNV NS 3
antibody (detected using FITC labeled secondary antibody) and GW182 (a), LSM-1 (b), DDX3 (c), DDX6 (d), XRN1 (e), DCP1a (f), EDC4 (g) XRN2 (h), dsRNA (i) antibodies
(detected using Alexaﬂour594 labeled secondary antibody) and examined by confocal microscopy. NS3/dsRNA costaining with ER marker calnexin is shown in (j). Individual
antibody stained as well as merged images are shown as indicated. Each experiment was repeated 2–3 times.
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knocked down the corresponding proteins both at mRNA and
protein levels as determined by qRT-PCR and Western blot respec-
tively (Fig. 4a and b). To determine if knockdown of P-body
components affect viral replication, the siRNA treated cells were
infected with WNV and viral replication monitored by FACS
analysis and qRT-PCR at 36 h PI. In LSM1 siRNA treated cells, there
was a 70% reduction in viral replication as indicated by reduction
in infected cells revealed by FACS analysis and viral RNA levels
revealed by qRT-PCR. For other P-body components, we observed a
moderate decrease in WNV infection levels (30%–50%) with the
least decrease observed in Dicer silenced cells (Fig. 4c and d).
However, knockdown of a non-P-body protein GAPDH did not
inﬂuence WNV replication (Fig. 4e), demonstrating the speciﬁcityof the effect of P-body component knockdown. These results
suggest that the P-body components are required for efﬁcient
WNV replication.
Taken together, our results show that many P-body compo-
nents are recruited to WNV replication sites and positively
regulate viral replication. More work is needed to determine
how exactly the P-body components inﬂuence WNV replication.
The 50 end of the genome of WNV contains a type I cap but the 30
end lacks a poly-(A) tail. Although the 50 cap of WNV enables
recruitment of the 40S ribosomal subunit via the eIF4F cap-
binding complex, because of lack of ploy-(A) tail, WNV RNA
cannot assume a ‘‘closed loop’’ conformation (which enhances
translation efﬁciency) due to lack of binding of the poly-(A)
binding protein (PABP) or the PABP-interacting protein-1.
Fig. 2. Continued.
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terminal genomic RNA structure have been hypothesized to
bridge the 50 and 30 termini (Brinton, 2002). In fact, several SG
and P-body proteins including DDX6, G3BP1, G3BP2, Caprin1, and
USP10, have recently been shown to bind DENV 30 UTRs and that
DDX6 assembly on the 30 UTR is required for DENV replication
(Ward et al., 2011). Thus, it is possible that P-body components
might serve to bridge the termini of WNV RNA to enhance
translation and/or replication. DDX6, LSM1, XRN1, PATL1 and
Ago2 have also been shown to be recruited to HCV replication
sites and it has been speculated that these P-body components
might be recruited to aid the enhancement of HCV replication by
the liver-speciﬁc miR-122. However, unlike HCV, no speciﬁc
miRNA has been reported to regulate WNV replication and
WNV shows no liver tropism. Thus, the recruitment of P-body
components may not be particularly relevant in the context of
miR-122, but is a common feature of ﬂaviviral infection. This isalso in line with a recent study that showed that DDX6 binds at
speciﬁc sites in the dengue viral 30 UTR and is required for
efﬁcient viral replication (Ward et al., 2011).
In addition to P-body components, several stress granule (SG)
components including TIA-1/TIAR in WNV infection and G3BP-1
and PABP-1 in HCV infection are also recruited to viral replication
sites. Moreover, the SG proteins G3BP1, G3BP2, Caprin1 and
USP10 have also been shown to bind to different regions in the
dengue virus 30 UTR. The reason why so many components of
P-bodies and SG are recruited to ﬂaviviral replication sites
remains to be determined, although it has been suggested that
they might inﬂuence switching between translation and replica-
tion of positive sense viral RNA and/or viral assembly, packaging
and egress (Beckham and Parker, 2008). It is noteworthy that
different viruses use the P-body and SG components in different
ways. For e.g., GW182, LSM1 and XRN1 appears to suppress HIV
infection from within the P-bodies, whereas ﬂaviviruses disrupt
Fig. 3. Recruitment of P-body components to viral replication sites occurs late during WNV infection. Uninfected and WNV infected HeLa cells were analyzed for
recruitment of LSM1 (a), GW182 (b), DDX3 (c) and XRN1 (d) at 12, 24 and 36 h post-infection as described in Fig. 2.
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poliovirus proteases cleave the PABP-1 and G3BP-1 to suppress
SG formation (Dougherty et al., 2011), whereas SG formation is
suppressed in HCV and WNV infection because of recruitment of
SG proteins at replication sites. Thus, it appears that P-body and
SG components play an important role in many virus infections
and viruses hijack these host proteins to their advantage in
different ways.Materials and methods
Cell and virus culture
HeLa and BHK-21 cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium (DMEM; Invitrogen, Carlsbad, CA) supplemented
with 10% fetal bovine serum (FBS). West Nile Virus (B956 strain,
ATCC) was grown and plaque titered on BHK-21 monolayers.
Fig. 4. P-body components positively regulate WNV replication. The siRNA knockdown of P-body components and GAPDH (an unrelated cellular protein control) was
conﬁrmed at both mRNA and protein level by qRT-PCR (a) and Western blot (b) respectively. mRNA (a) and protein (b) levels in untreated and corresponding siRNA treated
cells are shown. b actin served as loading control for Western blot analysis in (b). To study the effect of P-body component silencing on WNV replication, HeLa cells were
transfected with a pool of control siRNA (siGFP) or siRNAs speciﬁc for Ago2, DDX3, Dicer, LSM1 and GW182 siRNA using Lipofectamine 2000 and infected with WNV 24 h
after transfection. Thirty-six hours post-infection, the cells were tested for virus replication by FACS analysis after staining with a WNV envelope speciﬁc antibody (c) and
by qRT-PCR to detect WNV RNA levels (d). GAPDH silencing, used as an unrelated cellular protein control had no effect on WNV replication (e). MeanþSD of triplicate
experiments is shown.
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HeLa cells were uninfected or infected withWNV at multiplicity of
infection (MOI) of 2 and 36 h later, the cells lysed in a buffer
containing 50mM Tris–HCl (pH 8.0), 150 mM NaCl, 4 mM EDTA,
1% Nonidet P-40, 0.1% sodium dodecyl sulfate (SDS), 1 mM DTT, and
1mM phenylmethylsulfonyl ﬂuoride. Following a 30-min incubation
on ice, lysates were clariﬁed by centrifugation and protein concentra-
tions were determined using a detergent-compatible protein assay
kit (Pierce). Equal amounts of protein from these lysates were
electrophoretically separated on 4%–12% Nu-PAGE gels (Invitrogen)
by SDS-polyacrylamide gel electrophoresis, and electroblotted onto
polyvinylidene diﬂuoride membranes (Immobilon-P transfermembrane; Millipore). Following a blocking step with Tris-buffered
saline containing 0.1% Tween-20 and 5% dry milk, the membranes
were incubated with antibodies to LSM1, DDX6, GW182, XRN1,
DCP1a, DDX3, Dicer, Ago2, WNV NS3 and GAPDH followed by
horseradish peroxidase-conjugated secondary antibody (Peirce).
Bound horseradish peroxidase was visualized with an ECL substrate
kit (Thermo Scientiﬁc). Membranes were stripped and reprobed with
anti b-actin antibody (4967; Cell Signaling) as a loading control.
Immunostaining
HeLa cells grown on cover slips were either uninfected or infected
with WNV at indicated mois. At various times postinfection, the cells
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with 0.5% Triton X-100, and blocked (2% bovine serum albumin,
5% normal horse serum, and 10mM glycine in phosphatebuffered
saline) at room temperature. The cells were then incubated with anti-
GW182 (G5922; Sigma Aldrich) or anti-GW182 index human serum
(Kindly provided by Dr. Marvin J. Fritzler), anti-LSM1 (LS-C97364;
Life Span), anti-DDX3 antibody (54258 [IN]; Anaspec), anti-DDX6
(A300-460A; Bethyl), anti-XRN1 (A300-443A; Bethyl), anti-XRN2
(A301-103A; Bethyl), anti-DCP1a (AB47811; Abcam), anti-EDC4
(AB72408; Abcam), anti-dsRNA antibody J2 (J2-1101; English &
Scientiﬁc) anti-WNV-NS3/2b (MAB29071; R&D systems) and anti-
Calnexin (]2433; Cell Signaling) antibody at different dilutions in
PBS containing 3% bovine serum albumin (BSA) for 1 h at room
temperature. The cells were then stained with appropriate secondary
antibodies (AlexaFluor 594-conjugated anti-rabbit antibody and
ﬂuorescein isothiocyanate-conjugated anti-mouse antibody (Invitro-
gen)). Following extensive washing in PBS, the cells were mounted
onto slides using a mounting medium ProLong Gold (P36935;
Invitrogen) containing DAPI (4,6-diamidino-2-phenylindole) to stain
nuclei and reduce fading. The cells were visualized for P-body
components and WNV NS3/2b immunoﬂuorescence staining using
a Nikon Eclipse confocal/ﬂuorescence microscope (Nikon USA).
RNA interference
The following small interfering RNAs (siRNAs) were used: human
Ago2 (siGENOME SMRT pool M-013754-01-005), human DDX3
(siGENOME SMRT pool M-013754-01-005), human Dicer (siGEN-
OME SMRT pool M-013754-01-005), human LSM1 (siGENOME
SMRT pool M-005124-01-005), human GW182 (siGENOME SMRT
pool M-005124-01-005), (Dharmacon, Thermo Fisher Scientiﬁc,
Waltham, MA), human GAPDH (Sigma Aldrich) and GFP siRNA as
a control. HeLa cells (1105) were seeded in 24 well plates
overnight and transfected in triplicate with the above mentioned
siRNAs (100 pmole ﬁnal concentrations) using Lipofectamine-2000
(Invitrogen) according to the manufacturer’s instructions. The level
of WNV infection was determined by FACS analysis and qRT-PCR.
For FACS analysis, 36 h post-infection cells were harvested and
stained with anti-ﬂavivirus envelope speciﬁc antibody (4G2, ATCC).
Total RNA isolated from the infected cells using RNeasy minikit
(Qiagen, Hilden, Germany) was used for analysis of intracellular
WNV RNA level by qRT-PCR. qRT-PCR was performed using a SYBR
green PCR master Mix (Applied Biosystems) on 7900HT real-time
PCR system. Ampliﬁcation conditions were as follows: 40 cycles of
denaturation at 95 1C for 30 s, annealing at 55 1C for 30 s, and
extension at 72 1C for 30 s. The 18srRNA was used as an internal
control in all qRT-PCR assays and relative WNV viral RNA levels
were normalized with 18srRNA mRNA and calculated using the dCt
method. The forward and reverse primers sequences for 18srRNA
were GAGAAGACGGTCGAACTTGACT and ACCTACGGAAACCTTGT-
TACGA respectively. The forward and reverse primers for WNV
were ATCGCCGGACTTATGTTCG and CTTTCGCTAGAGCCTGTGATTT
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